Of the various factors that determine the choice of psychotropic drugs, economic cost to patients is often not adequately considered. The authors present results of a small survey ofprivate pharmacy prices for psychopharmacologic agents, and compare these prices with wholesale prices and prices f rom alternative retail sources. They report a large degree of price variability, which sometimes even overshadows price diffrences between trade and generic preparations. Problems with bioequivalency among different preparations, the ramifications ofprescribing the largest possible dose unit, and other issues related to drug cost are discussed.
Abstract Teaser